Literature DB >> 27398860

CROI 2016: Neurologic Complications of HIV Infection.

Serena S Spudich1, Beau M Ances2.   

Abstract

The brain remains a major target for HIV infection and a site of potential complications for HIV-infected individuals. Emerging data presented at the 2016 Conference on Retroviruses and Opportunistic Infections suggest that during the early stages of infection, activated CD4+ cells may traffic the virus into the central nervous system (CNS). HIV is detectable in cells and tissues of the CNS in some individuals despite suppressive antiretroviral treatment. A potential source of cerebrospinal fluid HIV escape may be compartmentalized HIV replication within macrophage lineage cells. Virally infected cells can traffic out of the CNS and may have the potential to reseed the systemic compartment. Additional modifiers of HIV-associated neurocognitive disorder (HAND) were identified, including female sex and hepatic dysfunction. Large epidemiologic studies reported an elevated risk of stroke among HIV-infected individuals, related to traditional vascular risk factors, history of recreational drug use, and HIV measures (lower CD4+ cell nadir and higher viral load). Brain imaging may provide a noninvasive means for detecting early changes in the brain associated with HIV infection and may assist in prognosis of HAND. Some potential adjunctive therapies to standard antiretroviral therapy for HIV-infected individuals were considered.

Entities:  

Mesh:

Year:  2016        PMID: 27398860      PMCID: PMC6148921     

Source DB:  PubMed          Journal:  Top Antivir Med        ISSN: 2161-5853


  12 in total

1.  Low levels of HIV-1 RNA detected in the cerebrospinal fluid after up to 10 years of suppressive therapy are associated with local immune activation.

Authors:  Viktor Dahl; Julia Peterson; Dietmar Fuchs; Magnus Gisslen; Sarah Palmer; Richard W Price
Journal:  AIDS       Date:  2014-09-24       Impact factor: 4.177

Review 2.  HIV-associated neurocognitive disorder.

Authors:  David B Clifford; Beau M Ances
Journal:  Lancet Infect Dis       Date:  2013-11       Impact factor: 25.071

3.  HIV status and the risk of ischemic stroke among men.

Authors:  Jason J Sico; Chung-Chou H Chang; Kaku So-Armah; Amy C Justice; Elaine Hylek; Melissa Skanderson; Kathleen McGinnis; Lewis H Kuller; Kevin L Kraemer; David Rimland; Matthew Bidwell Goetz; Adeel A Butt; Maria C Rodriguez-Barradas; Cynthia Gibert; David Leaf; Sheldon T Brown; Jeffrey Samet; Lewis Kazis; Kendall Bryant; Matthew S Freiberg
Journal:  Neurology       Date:  2015-04-10       Impact factor: 9.910

4.  Vascular risk factors, HIV serostatus, and cognitive dysfunction in gay and bisexual men.

Authors:  J T Becker; L Kingsley; J Mullen; B Cohen; E Martin; E N Miller; A Ragin; N Sacktor; O A Selnes; B R Visscher
Journal:  Neurology       Date:  2009-10-20       Impact factor: 9.910

5.  Factors associated with neurocognitive test performance at baseline: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.

Authors:  E J Wright; B Grund; L A Cysique; K R Robertson; B J Brew; G Collins; J C Shlay; A Winston; T R H Read; R W Price
Journal:  HIV Med       Date:  2015-04       Impact factor: 3.180

Review 6.  Controversies in HIV-associated neurocognitive disorders.

Authors:  Sam Nightingale; Alan Winston; Scott Letendre; Benedict D Michael; Justin C McArthur; Saye Khoo; Tom Solomon
Journal:  Lancet Neurol       Date:  2014-11       Impact factor: 44.182

7.  Cerebral white matter integrity during primary HIV infection.

Authors:  Patrick W Wright; Florin F Vaida; Ricardo J Fernández-de Thomas; Jerrel Rutlin; Richard W Price; Evelyn Lee; Julia Peterson; Dietmar Fuchs; Joshua S Shimony; Kevin R Robertson; Rudolph Walter; Dieter J Meyerhoff; Serena Spudich; Beau M Ances
Journal:  AIDS       Date:  2015-02-20       Impact factor: 4.632

8.  Structural and functional features of central nervous system lymphatic vessels.

Authors:  Antoine Louveau; Igor Smirnov; Timothy J Keyes; Jacob D Eccles; Sherin J Rouhani; J David Peske; Noel C Derecki; David Castle; James W Mandell; Kevin S Lee; Tajie H Harris; Jonathan Kipnis
Journal:  Nature       Date:  2015-06-01       Impact factor: 49.962

9.  Brain alterations within the first 100 days of HIV infection.

Authors:  Ann B Ragin; Ying Wu; Yi Gao; Sheila Keating; Hongyan Du; Christina Sammet; Casey S Kettering; Leon G Epstein
Journal:  Ann Clin Transl Neurol       Date:  2014-12-18       Impact factor: 4.511

10.  Neurocognitive decline in HIV patients is associated with ongoing T-cell activation in the cerebrospinal fluid.

Authors:  Oliver M Grauer; Doris Reichelt; Ute Grüneberg; Hubertus Lohmann; Tilman Schneider-Hohendorf; Andreas Schulte-Mecklenbeck; Catharina C Gross; Sven G Meuth; Heinz Wiendl; Ingo W Husstedt
Journal:  Ann Clin Transl Neurol       Date:  2015-08-18       Impact factor: 4.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.